Dr Richard Antrobus talks about his research in the development of a universal flu vaccines.
Universal Flu Vaccine
Universal flu vaccines target specific parts of the influenza virus that stay relatively stable between different strains of flu. Dr Richard Antrobus is conducting a Phase I study for a universal influenza vaccine. Progress so far indicates that this approach induces a potent T cell response, and Dr Antrobus is assessing whether this response is equally potent in the elderly - one of the 'at risk' groups of the influenza virus. If successful this vaccine will protect against a wide range of strains of the virus.
Series:
People:
Oxford Unit:
Keywords:
More in this Series...
Vaccines save millions of lives each year; however, some of the world's worst diseases are still difficult to prevent. Our series of podcasts on Epidemics and Vaccines detail the research within NDM to combat diseases such as hepatitis, influenza and tuberculosis, through development of novel vaccines and vaccine delivery mechanisms and strategies. Developing countries and vulnerable populations are a particular focus of some of this work.